Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes: A Long-Term Cost-Effectiveness Analysis in Estonia
每周一次索玛鲁肽与每日一次利拉鲁肽治疗2型糖尿病：爱沙尼亚的一项长期成本效益分析
期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-018-0542-x
Malkin, Samuel J P; Russel-Szymczyk, Monika; Liidemann, Girtel; Volke, Vallo; Hunt, Barnaby
